Press Releases

Date	Title	Company
04-Jun-2021	Radiology Market 2021 Share, Size, Growth, Future Demand by Major Players-GENERAL ELECTRIC COMPANY, Siemens Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Hitachi Medical Systems, Carestream Health	CDN Newswire
04-Jun-2021	4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update	4D pharma
04-Jun-2021	Effervescent Tablet Market Growth Drivers, Demands, Business Opportunities, Size, Share, Global Trends and Analysis by Top Leading Players-Bayer Ag, GlaxoSmithKline PLC, Prestige Brands	CDN Newswire
04-Jun-2021	Liposome Drug Delivery Market 2021-Industry Size, Share, Business Growth, Revenue, Trends, Top Players-Johnson & Johnson Services , Takeda Pharmaceutical, Novartis AG, Astellas Pharma	CDN Newswire
04-Jun-2021	Patient Lifting Equipment Market 2021-Industry Trends, Size, Growth Insight, Share, Emerging Technologies\| Arjo, DJO Global, Hill-Rom Services, Invacare	CDN Newswire
04-Jun-2021	New Phase 3b Psoriatic Arthritis (PsA) Data Show TREMFYA® ▼ (guselkumab) Achieved Sustained Improvement in Joint Symptoms and Rate of Complete Skin Clearance in Patients with Inadequate Response to Tumour Necrosis Factor Inhibition (TNFi-IR)	Janssen
04-Jun-2021	Smart Diabetes Management Market Size 2021-Global Business Strategies, Growing CAGR o14.50%, Industry Revenue, Opportunities, Future Trends, Leading Players-F. Hoffmann-La Roche Ltd, Medtronic, Dexcom	CDN Newswire
04-Jun-2021	Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027	BlueWeave Consulting
04-Jun-2021	Ostomy Care Market Worth USD 3.5 Billion – A Surge in Cancer Cases to Fuel Market Growth	MarketsandMarkets Research Private Ltd.
04-Jun-2021	Eurofins Core Business Strong Organic Growth Further Accelerates in April	Businesswire
04-Jun-2021	Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities	Avance Clinical
03-Jun-2021	INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ)	Businesswire
03-Jun-2021	Clinical Trial Results of the BCMA CAR-T Co-developed by IASO Biotherapeutics and Innovent Commented in American Society of Hematology’s Medical Journal, Blood	Businesswire
03-Jun-2021	Privo Technologies, Inc. to Present Phase II Data for PRV111 in Head and Neck Squamous Cell Carcinoma at the Upcoming 2021 ASCO Annual Meeting	Newswire
03-Jun-2021	Kansas Manufacturing Solutions and BioKansas Partner to Help Kansas Biomanufacturers Prosper	Businesswire
03-Jun-2021	IGEA announces changes in its board and other corporate updates	IGEA Pharma N.V.
03-Jun-2021	Bristol Myers Squibb Presents Data from CheckMate -648 Showing Opdivo plus Chemotherapy and Opdivo plus Yervoy Significantly Improved Overall Survival Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma	Businesswire
03-Jun-2021	LYNPARZA® (olaparib) Reduced the Risk of Invasive Disease Recurrence or Death by 42% Versus Placebo in Adjuvant Treatment of Patients With Germline BRCA Mutations and High-Risk HER2-Negative Early Breast Cancer in Phase 3 OlympiA Trial	Businesswire
03-Jun-2021	LYNPARZA® (olaparib) reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial	Businesswire
03-Jun-2021	Merck’s KEYTRUDA® (pembrolizumab) Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC)	Businesswire